JB
2.1K posts

JB
@JBMason
if you’re going to try, go all the way menswear and a bit more


There are sunglasses. And then there is Oliver Peoples.



For the past 6 months I've gotten away from using an Apple watch, Oura, Whoop, and any other type of wearable. I've noticed no changes in my physical health but a positive change in my mental health as I've stopped using a piece of tech to tell me how I should feel.




one day you’re 25 and the next you’re getting sorted into one of the four stroller houses for your baby


The NYT just profiled a $1.8B revenue company with 2 employees. Medvi is a telehealth GLP-1 provider built by Matthew Gallagher, 41, from his house in LA. He launched in September 2024 with $20,000. Here are the numbers: Month 1: 300 customers Month 2: 1,300 customers 2025 full year: $401M revenue, 250,000 customers 2026 run rate: $1.8B Net margin: 16.2% ($65M profit) Total employees: 2 (him and his brother) Outside funding: $0 How it works: Medvi is a front end. Two platforms — CareValidate and OpenLoop Health — handle doctors, prescriptions, pharmacies, shipping, and compliance. Gallagher handles brand, website, ads, checkout, and customer service. All built with AI. His stack: ChatGPT, Claude, and Grok for code. Midjourney and Runway for ad creative. ElevenLabs for voice. Custom AI agents to connect systems. AI chatbot for customer service (which initially hallucinated fake prices he had to honor). For comparison: Hims & Hers did $2.4B revenue last year with 2,442 employees and 5.5% net margins. Gallagher is running 3x the margin with a fraction of a percent of the headcount. Back into the unit economics: ~$336M in total costs, probably $160-200M to the telehealth platforms, leaving $130-170M mostly in marketing. Against 250,000 customers, that's a $500-700 CAC. High, but it works because his overhead is virtually zero and LTV at ~$200/month holds up. He's expanding fast. Men's health launched in February — 50K customers in month one. Meal delivery went live last month. Women's health, hair growth, supplements, and skincare are next. The vulnerability: zero moat. No proprietary tech, no doctor network, no pharmacy infrastructure. CareValidate or OpenLoop could raise fees or launch competing brands. Anyone could replicate this model in weeks. Right now, the margins are enormous for anyone who moves fast enough. The question is how long that window stays open. nytimes.com/2026/04/02/tec…

While you hyperventilate over your "readiness" or "recovery" score and how many hours of REM sleep you got the night before you have guys like JJ Spaun just showing up and getting it done. 👇 Parents everywhere know the deal. "Optimization" is a fool's errand. Excerpt taken from Growth Equation: thegrowtheq.com/newsletters/





I really dislike stores that function more as art galleries than places to shop One size of each garment and when you ask the douchebag employee if they have what you want in stock they act as if you’ve just asked them to defuse landmines in Vietnam

















